Another drug stock tanks on Citron short threat
November 09, 2015 at 14:42 PM EST
Shares of Mallinckrodt fell as much as 25 percent after Citron Research tweeted the company had more downside than Valeant at these levels.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.